CRL
Charles River provides essential early-stage drug development and preclinical research services, specializing in animal models, toxicology, and translational biology to support biopharmaceutical discovery and development. With global laboratories and vivarium facilities, they offer expertise in in vivo pharmacology, pharmacokinetics, and bioanalysis to advance medicines from early discovery to candidate selection. The company operates internationally, serving pharmaceutical, biotechnology, and academic clients across multiple regions.